SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-23-005932
Filing Date
2023-09-28
Accepted
2023-09-28 17:01:30
Documents
16
Period of Report
2023-09-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_092823.htm   iXBRL 8-K 20426
2 EXHIBIT 10.1 exh_101.htm EX-10.1 26300
3 PRESS RELEASE exh_991.htm EX-99.1 6501
4 logo.jpg GRAPHIC 7754
  Complete submission text file 0001171843-23-005932.txt   275402

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE gnw-20190101.xsd EX-101.SCH 3003
6 XBRL DEFINITION FILE gnw-20190101_def.xml EX-101.DEF 25598
7 XBRL LABEL FILE gnw-20190101_lab.xml EX-101.LAB 34011
8 XBRL PRESENTATION FILE gnw-20190101_pre.xml EX-101.PRE 22139
10 EXTRACTED XBRL INSTANCE DOCUMENT f8k_092823_htm.xml XML 3035
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32979 | Film No.: 231290664
SIC: 2834 Pharmaceutical Preparations